{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:43:08Z","timestamp":1766155388763,"version":"3.44.0"},"reference-count":20,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,2,14]]},"abstract":"<jats:p>Drug-induced liver injury is the fourth most common cause of liver disease in industrialised countries. Methylprednisolone is often considered to be a treatment with a low hepatotoxicity. We report a case of methylprednisolone-induced liver injury in a 35-year-old woman. She was admitted to our department for acute liver injury 2\u2009months after a treatment with high dose of methylprednisolone (1\u2009g\/day) for a multiple sclerosis relapse. No other cause of liver injury could be found (screening for hepatotropic viruses, autoimmune antibodies, ceruloplasmin, abdominal ultrasonography and liver biopsy). Liver function tests spontaneously improved and returned to normal range within 6 weeks. We also performed a brief review of the literature and identified 12 other cases of methylprednisolone-induced liver injury in patients treated for multiple sclerosis relapse. An immune rebound phenomenon could be responsible for rare but true hepatotoxicity of high-dose methylprednisolone therapy.<\/jats:p>","DOI":"10.1136\/bcr-2017-223670","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T09:15:29Z","timestamp":1520241329000},"page":"bcr-2017-223670","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Methylprednisolone-induced acute liver injury in a patient treated for multiple sclerosis relapse"],"prefix":"10.1136","volume":"2018","author":[{"given":"Clement","family":"Bresteau","sequence":"first","affiliation":[{"name":"Department of Hepato Gastroenterology and Nutirtion, Hopital Antoine-Beclere, Clamart, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Prevot","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hopital Antoine-Beclere, Clamart, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Perlemuter","sequence":"additional","affiliation":[{"name":"Department of Hepato Gastroenterology and Nutirtion, Hopital Antoine-Beclere, Clamart, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosmin","family":"Voican","sequence":"additional","affiliation":[{"name":"Department of Hepato Gastroenterology and Nutirtion, Hopital Antoine-Beclere, Clamart, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34857"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2005.05.006"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.3","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.131"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.4","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.gcb.2009.10.003","article-title":"[Hepatotoxicity of drugs and chemicals]","volume":"33","author":"Larrey","year":"2009","journal-title":"Gastroenterol Clin Biol"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.2.169"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.6","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(93)90101-6"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2004.10.018"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.8","first-page":"314","article-title":"Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis","volume":"25","author":"Das","year":"2006","journal-title":"Indian J Gastroenterol"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.9","first-page":"720","article-title":"[Recurrent acute liver toxicity from intravenous methylprednisolone]","volume":"100","author":"Rivero Fern\u00e1ndez","year":"2008","journal-title":"Rev Esp Enferm Dig"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.10","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3748\/wjg.14.5474","article-title":"Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report","volume":"14","author":"Takahashi","year":"2008","journal-title":"World J Gastroenterol"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.11","first-page":"356","article-title":"Autoimmune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS","volume":"2","author":"Reu\u00df","year":"2007","journal-title":"Central European J Med"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clinre.2012.10.015","article-title":"Acute liver toxicity due to methylprednisolone: consider this diagnosis in the context of autoimmunity","volume":"37","author":"Carrier","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000323835","article-title":"Recurrent high-dose intravenous methylprednisolone succinate pulse therapy-induced hepatopathy in a patient with multiple sclerosis","volume":"20","author":"Furutama","year":"2011","journal-title":"Med Princ Pract"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.14","first-page":"199","article-title":"High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: a case report and brief review of literature","volume":"71","author":"D\u2019Agnolo","year":"2013","journal-title":"Neth J Med"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/liv.12607","article-title":"Incomplete septal cirrhosis after high-dose methylprednisolone therapy and regression of liver injury","volume":"35","author":"Grilli","year":"2015","journal-title":"Liver Int"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/1751-2980.12306","article-title":"Methylprednisolone-induced liver injury: Case report and literature review","volume":"17","author":"Davidov","year":"2016","journal-title":"J Dig Dis"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.17","doi-asserted-by":"publisher","DOI":"10.5812\/kowsar.1735143X.641"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clinre.2017.03.008","article-title":"Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey","volume":"41","author":"Dumortier","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.19","unstructured":"Corticosteroids. LiverTox Web site. 2017 ttps:\/\/livertox.nlm.nih.gov\/\/Corticosteroids.htm"},{"key":"2025082803550332000_2018.mar05_1.bcr-2017-223670.20","doi-asserted-by":"publisher","DOI":"10.1089\/105072504774193276"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-223670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:55:11Z","timestamp":1756378511000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-223670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":20,"alternative-id":["10.1136\/bcr-2017-223670"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-223670","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,3,5]]}}}